These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25879650)

  • 21. Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009.
    von Gottberg A; Cohen C; Whitelaw A; Chhagan M; Flannery B; Cohen AL; de Gouveia L; Plessis Md; Madhi SA; Klugman KP;
    Vaccine; 2012 Jan; 30(3):565-71. PubMed ID: 22119925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign.
    Ladhani S; Slack MP; Heys M; White J; Ramsay ME
    Arch Dis Child; 2008 Aug; 93(8):665-9. PubMed ID: 17942585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemophilus influenzae type b (Hib) vaccine: an effective control strategy in India.
    Verma R; Khanna P; Chawla S; Bairwa M; Prinja S; Rajput M
    Hum Vaccin; 2011 Nov; 7(11):1158-60. PubMed ID: 22048118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemophilus influenzae type b reemergence after combination immunization.
    Johnson NG; Ruggeberg JU; Balfour GF; Lee YC; Liddy H; Irving D; Sheldon J; Slack MP; Pollard AJ; Heath PT
    Emerg Infect Dis; 2006 Jun; 12(6):937-41. PubMed ID: 16707049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring the impact of conjugate vaccines on invasive Haemophilus influenzae type b infection in Western Australia.
    Bower C; Condon R; Payne J; Burton P; Watson C; Wild B
    Aust N Z J Public Health; 1998 Feb; 22(1):67-72. PubMed ID: 9599855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.
    Klein NP; Abu-Elyazeed R; Cornish M; Leonardi ML; Weiner LB; Silas PE; Grogg SE; Varman M; Frenck RW; Cheuvart B; Baine Y; Miller JM; Leyssen M; Mesaros N; Roy-Ghanta S
    Vaccine; 2017 Jun; 35(28):3564-3574. PubMed ID: 28536030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of radiologically-confirmed pneumonia and Haemophilus influenzae type b carriage before Haemophilus influenzae type b conjugate vaccine introduction in Central Vietnam.
    Yoshida LM; Nguyen HA; Watanabe K; Le MN; Nguyen AT; Vu HT; Yoshino H; Suzuki M; Takahashi K; Le T; Moriuch H; Kilgore PE; Edmond K; Mulholland K; Dang DA; Ariyoshi K
    J Pediatr; 2013 Jul; 163(1 Suppl):S38-43. PubMed ID: 23773592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection.
    Madhi SA; Petersen K; Khoosal M; Huebner RE; Mbelle N; Mothupi R; Saloojee H; Crewe-Brown H; Klugman KP
    Pediatr Infect Dis J; 2002 Apr; 21(4):315-21. PubMed ID: 12075763
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Slack M; Esposito S; Haas H; Mihalyi A; Nissen M; Mukherjee P; Harrington L
    Expert Rev Vaccines; 2020 Oct; 19(10):903-917. PubMed ID: 32962476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines.
    Mangtani P; Mulholland K; Madhi SA; Edmond K; O'Loughlin R; Hajjeh R
    Vaccine; 2010 Feb; 28(7):1677-83. PubMed ID: 20034606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007.
    Scheifele DW; Bettinger JA; Halperin SA; Law B; Bortolussi R
    Pediatr Infect Dis J; 2008 Aug; 27(8):755-7. PubMed ID: 18594482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the introduction of the Haemophilus influenzae type b conjugate vaccine in an urban setting in southern India.
    Fitzwater SP; Ramachandran P; Kahn GD; Nedunchelian K; Suresh S; Santosham M; Chandran A
    Vaccine; 2019 Mar; 37(12):1608-1613. PubMed ID: 30772069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules.
    Hong E; Terrade A; Denizon M; Aouiti-Trabelsi M; Falguières M; Taha MK; Deghmane AE
    BMC Infect Dis; 2021 Jul; 21(1):715. PubMed ID: 34330228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ten years of Hib vaccination in Italy: prevalence of non-encapsulated Haemophilus influenzae among invasive isolates and the possible impact on antibiotic resistance.
    Giufrè M; Cardines R; Caporali MG; Accogli M; D'Ancona F; Cerquetti M
    Vaccine; 2011 May; 29(22):3857-62. PubMed ID: 21459175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan.
    Kitano T; Aoki H
    Vaccine; 2021 Jan; 39(2):343-349. PubMed ID: 33280853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. I. Total antibodies.
    Zarei AE; Redwan EM
    Hum Antibodies; 2018; 26(4):225-235. PubMed ID: 29945350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A nationwide prospective surveillance study in Israel to document pediatric invasive infections, with an emphasis on Haemophilus influenzae type b infections. Israeli Pediatric Bacteremia and Meningitis Group.
    Dagan R; Fraser D; Greif Z; Keller N; Kaufstein M; Shazberg G; Schlesinger M
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S198-203. PubMed ID: 9781763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric invasive Haemophilus influenzae infections in Israel in the era of Haemophilus influenzae type b vaccine: a nationwide prospective study.
    Bamberger EE; Ben-Shimol S; Abu Raya B; Katz A; Givon-Lavi N; Dagan R; Srugo I;
    Pediatr Infect Dis J; 2014 May; 33(5):477-81. PubMed ID: 24445822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era.
    Nix EB; Hawdon N; Gravelle S; Biman B; Brigden M; Malik S; McCready W; Ferroni G; Ulanova M
    Clin Vaccine Immunol; 2012 May; 19(5):766-71. PubMed ID: 22398246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
    Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.